DOMINANCE OF MTOR INHIBITORS IN BREAST CANCER: BROAD ANTINEOPLASTIC EFFECT
$37,456P20FY2008RRNIH
University Of Delaware, Newark DE
Investigators
Linked publications & trials
Paper 39574616Paper 32086248Paper 30858832Paper 30327611Paper 29176519Paper 29151616Paper 28487386Paper 27598560Paper 27461855Paper 27391562Paper 27121868Paper 26788781Paper 26657765Paper 26478759Paper 26404792Paper 26382850Paper 26357273Paper 26286140Paper 26078434Paper 26016692Paper 25766952Paper 25619714Paper 25451031Paper 25364780Paper 25356090Paper 25302340Paper 25271780Paper 25226261Paper 25059238Paper 25052069Paper 24966085Paper 24919202Paper 24797878Paper 24668743Paper 24653958Paper 24607497Paper 24526906Paper 24495224Paper 24478935Paper 24341952Paper 24300854Paper 24273464Paper 24161570Paper 24151020Paper 24084210Paper 24039625Paper 23999276Paper 23985748Paper 23976945Paper 23956463Paper 23955776Paper 23911941Paper 23810808Paper 23768461Paper 23766781Paper 23735279Paper 23667656Paper 23643050Paper 23549265Paper 23459473Paper 23427941Paper 23418186Paper 23394107Paper 23318255Paper 23263240Paper 23212305Paper 23161024Paper 23147645Paper 23145637Paper 23116119Paper 23022133Paper 22981897Paper 22907057Paper 22849291Paper 22834767Paper 22812610Paper 22780318Paper 22713599Paper 22711008Paper 22652364Paper 22615105Paper 22549440Paper 22473760Paper 22434832Paper 22374788Paper 22356985Paper 22356984Paper 22303090Paper 22273344Paper 22271446Paper 22189905Paper 22188767Paper 22128187Paper 22128142Paper 22102590Paper 22087942Paper 22023267Paper 21934539Paper 21927715Paper 21881623
View original record on NIH RePORTER →